What is the current market size?

The External Urine Management Devices market size was valued at USD 1.2 billion in 2023, driven by rising geriatric populations and chronic urological conditions.

What is the expected growth rate?

The market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033, reaching USD 1.8 billion by 2033.

What are the key growth drivers?

Key drivers include aging demographics, increasing prevalence of urinary incontinence, and advancements in wearable and disposable device technologies.

What challenges does the market face?

Challenges include product-related complications like skin irritation, high costs, and regulatory hurdles in emerging economies.

Which regions lead the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region.

Who are the top companies?

Leading companies include B. Braun, Coloplast, Medtronic, and Hollister, focusing on innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in expanding telehealth integration, biodegradable materials, and demand in emerging markets like India and China.

How is technology impacting the market?

Smart devices with IoT connectivity and improved adhesives are enhancing user comfort and compliance, driving market growth.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA mandate rigorous testing for safety and efficacy, ensuring high-quality standards for devices.

How does the market address patient needs?

Products prioritize discreet designs, leak-proof systems, and skin-friendly materials to improve quality of life for users.

Global External Urine Management Devices Market Value Is Forecast To Reach By 2034 With CAGR

External Urine Management Devices by Application (Hospitals, Clinics, Home Care, Others), by Types (Condom Caths, Indwelling Caths, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $586 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $586 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

External Urine Management Devices Market Overview

The External Urine Management Devices (EUMD) market encompasses disposable and reusable systems designed to collect and manage urinary waste externally, primarily for patients with incontinence or mobility challenges. These devices play a critical role in enhancing patient comfort and hygiene, particularly in geriatric care and post-operative recovery settings. The EUMD market size is projected to exceed $1.8 billion by 2033, reflecting robust growth outlook driven by aging demographics, rising prevalence of urological disorders, and advancements in wearable medical technologies.

Loading chart…

The EUMD market forecast highlights a 5.5% CAGR (2026–2033), with North America dominating the industry due to high adoption of advanced urological care and stringent regulatory frameworks. Conversely, the Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding healthcare infrastructure and rising awareness of non-invasive treatment options. Key industry expansion drivers include innovations in antimicrobial coatings, demand for discreet, odor-free designs, and telehealth integration for remote patient monitoring. Regulatory standardization and partnerships between manufacturers and home healthcare providers are also reshaping competitive dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	586.00 million
Revenue forecast in 2033	1.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD Company; Stryker (including Sage); Teleflex; B. Braun; Coloplast; Hollister; Cardinal Health; Boehringer Laboratories; Men’s Liberty; TillaCare; Consure Medical; Sterimed Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The External Urine Management Devices market is expanding due to the rising prevalence of urological disorders such as benign prostatic hyperplasia (BPH) and prostate cancer, particularly in aging populations. This demographic shift is amplifying demand for non-invasive, user-friendly solutions.

Advancements in product design, including lightweight and discreet devices, are enhancing patient compliance and market adoption. Innovations in adhesive technology and materials are also addressing leakage concerns, a key differentiator in a competitive landscape.

Restraints2 items

High costs associated with premium devices, coupled with limited reimbursement policies in emerging markets, are restricting accessibility. This cost barrier disproportionately affects low-income patient segments.

Regulatory complexities, such as stringent approvals in the EU and U.S., are delaying market entry for new competitors. Stringent compliance requirements for medical devices add operational costs and slow innovation cycles.

Opportunities2 items

The External Urine Management Devices market size is projected to grow significantly in Asia-Pacific due to improving healthcare infrastructure and rising awareness about urological health in countries like India and China.

Integration of smart monitoring technologies, such as IoT-enabled sensors for real-time fluid tracking, could unlock premium pricing and cater to high-growth segments like geriatric care and home healthcare.

Challenges2 items

Cultural stigmas surrounding incontinence and urological issues remain a barrier to adoption, particularly in conservative regions. This necessitates aggressive patient education and caregiver-focused marketing strategies.

Supply chain vulnerabilities, including raw material shortages and geopolitical trade tensions, are creating pricing volatility. Manufacturers face pressure to secure alternative suppliers without compromising quality.

Market Segmentation

Loading chart…

The External Urine Management Devices market is segmented by Application into Incontinence Management and Post-Operative Care. Incontinence Management constitutes the largest share, driven by rising prevalence of urinary incontinence among aging populations and chronic conditions such as diabetes and prostate disorders. This segment benefits from home healthcare demand and growing awareness of non-invasive treatment options. Post-Operative Care focuses on temporary urine management following urological surgeries, where catheterization or external drainage systems are critical for recovery. While smaller than the incontinence segment, this application is growing due to the increasing incidence of surgical procedures and hospital-acquired infections. Together, these applications define the External Urine Management Devices segmentation by functional need, with healthcare infrastructure development and patient demographics shaping regional market dynamics.

By Types, the market includes External Urine Collection Systems and External Urine Drainage Systems. Collection Systems are designed for long-term urine retention, often used in home settings for patients with chronic incontinence. These systems prioritize comfort and leakage prevention, leveraging advanced materials for durability. Drainage Systems are primarily hospital-based, facilitating continuous urine flow monitoring and management for post-operative patients. Drainage systems emphasize sterility and integration with medical devices like urinary catheters. The dominance of Collection Systems in the market is attributed to their adaptability for ambulatory care, while Drainage Systems see demand in acute-care facilities. This typology underscores the market taxonomy’s alignment with care environments, reflecting technological innovation and unmet clinical needs across patient cohorts.

External Urine Management Devices Segmentation Breakdown9 items

Application

Hospitals

Clinics

Home Care

Others

Types

Condom Caths

Indwelling Caths

Others

Regional Insights

Loading chart…

North America dominates the External Urine Management Devices market growth with a 40% market share, driven by advanced healthcare infrastructure, high geriatric adoption, and robust reimbursement policies. The region’s ecosystem maturity, supported by regulatory clarity and R&D investments, ensures sustained demand. Europe follows closely at 30%, propelled by aging demographics, stringent hygiene regulations, and public-private partnerships in healthcare innovation. Germany and the UK lead adoption due to proactive aging population healthcare strategies.

Asia Pacific emerges as the fastest-growing region, capturing 15% of the market, fueled by rising chronic disease prevalence, urbanization, and expanding medical device manufacturing ecosystems. Japan’s aging population and India’s improving healthcare infrastructure are key growth levers. Latin America (10%) and the Middle East & Africa (5%) show potential due to increasing investment in hospital infrastructure and chronic disease management programs, though adoption remains constrained by uneven healthcare access and economic disparities.

The regional forecast for External Urine Management Devices underscores Asia Pacific’s trajectory, supported by demographic shifts and policy-driven healthcare digitization. North America and Europe will maintain leadership through ecosystem innovation, while emerging markets target market share gains via infrastructure upgrades and affordability initiatives.

Competitive Landscape

The External Urine Management Devices competitive landscape is moderately consolidated, characterized by a mix of global players and regional manufacturers. Key global firms such as BD and Stryker dominate through advanced product portfolios and regulatory approvals, while regional entities like TillaCare and Consure Medical target niche markets via cost-competitive offerings. Competitive differentiation hinges on product innovation (e.g., antimicrobial coatings, odor control), pricing flexibility, and channel strength in emerging markets. Regulatory compliance and rapid FDA/CE marking approvals remain critical barriers to entry. Pricing pressures are evident in commodity-grade segments, with mid-tier players leveraging localized production to offset margin erosion.

Strategic priorities include R&D for premium features (e.g., smart monitoring systems) and geographic expansion into Asia-Pacific and Latin America. Partnerships with healthcare providers and OEM agreements are common to secure distribution in institutional settings. However, margin compression from generic competitors and rising raw material costs challenge profitability. Differentiation also stems from service models—such as Coloplast’s homecare support programs—and customization capabilities for urology specialists. Supply chain disruptions and stringent compliance costs further intensify operational complexity for smaller players.

BD: R&D investment in antimicrobial catheter coatings

Stryker (Sage): Portfolio expansion via acquisition of niche OEMs

Teleflex: Vertical integration to secure raw material sourcing

B. Braun: Cost advantages through local manufacturing in Asia

Coloplast: Diversified product lines targeting chronic urology patients

Hollister: Strategic partnerships with hospital procurement networks

Key External Urine Management Devices Companies12 items

BD Company

Stryker (including Sage)

Teleflex

B. Braun

Coloplast

Hollister

Cardinal Health

Boehringer Laboratories

Men’s Liberty

TillaCare

Consure Medical

Sterimed Group

Market Ecosystem

The External Urine Management Devices ecosystem spans upstream raw material suppliers, midstream manufacturers and integrators, and downstream healthcare providers and patients. Value is generated through material innovation, device design, and post-market support, with regulatory compliance and clinical validation acting as critical enablers. The ecosystem balances technological development with end-user accessibility across care settings.

Raw material/component suppliers — supply polymers, adhesives, and absorbent materials for device production

OEMs/Manufacturers — design and produce external urine management devices for medical and home use

Technology providers — develop sensor or monitoring technologies for smart urine management systems

Distributors/Channel partners — manage logistics and supply chains to healthcare providers and retail pharmacies

Service providers/After-sales — handle installation, training, and maintenance for institutional buyers

End users — include hospitals, long-term care facilities, and individuals with urological conditions

Regulators/standards bodies — set compliance and safety certifications for product market entry

Control points reside with regulators, who dictate approval timelines and product specifications, and raw material suppliers, whose input costs impact pricing. Dependency risks emerge from supply chain disruptions or regulatory revisions. Institutional buyers face high switching costs due to integration with existing care protocols, while interoperability with telehealth systems is increasingly prioritized. Regional divergence exists in reimbursement frameworks and adoption rates of digital-enabled devices.

Recent Industry Insights

The External Urine Management Devices industry trends have evolved rapidly over the past 18 months, driven by innovations in smart healthcare and a focus on patient-centric solutions. Key developments include telehealth partnerships enabling remote monitoring via connected devices, M&A activity consolidating market players to enhance R&D capabilities, and regulatory updates promoting biocompatible materials. Consumer demand for discreet, lightweight designs has spurred the launch of antimicrobial-coated products and wearable-friendly systems, while funding rounds totaling over $150 million in 2024 highlight investor confidence in tech-driven solutions.

Recent Developments in the _External Urine Management Devices_ industry trends4 items

B. Braun acquired a specialty medical device startup in 2024 to expand its portfolio of urological solutions.

Smith & Nephew launched a connected catheter system with real-time flow monitoring in early 2025.

The FDA introduced updated guidelines in 2024 to accelerate approval for devices incorporating antimicrobial polymers.

Startups like UroTech raised $20 million in 2024 for AI-powered urinary health analytics platforms.

Analyst Overview

The External Urine Management Devices market outlook remains robust, driven by an aging global population and rising prevalence of urological disorders. Market attractiveness is underscored by steady demand from chronic care and post-surgical applications, with emerging economies offering untapped growth potential. Competitive intensity is moderate, characterized by established players dominating premium segments and niche innovators targeting cost-effective solutions. Long-term growth is projected at a CAGR exceeding 5%, fueled by technological advancements in wearable and smart devices. The innovation landscape is evolving rapidly, with a focus on user-centric design and smart monitoring integration to enhance patient compliance. Demand-supply balance remains stable, though supply chain disruptions and raw material volatility pose recurring challenges. Key risk factors include regulatory scrutiny in high-income markets and pricing pressures in mature healthcare systems. Strategic partnerships and R&D investments will be critical for sustaining market relevance.

12 items

1. Executive Summary

2. External Urine Management Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global External Urine Management Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global External Urine Management Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global External Urine Management Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global External Urine Management Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global External Urine Management Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global External Urine Management Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global External Urine Management Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global External Urine Management Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global External Urine Management Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global External Urine Management Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global External Urine Management Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global External Urine Management Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global External Urine Management Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global External Urine Management Devices Market Competition by Key Manufacturers

9.1. Global External Urine Management Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global External Urine Management Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Stryker (including Sage)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Teleflex

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B. Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Coloplast

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hollister

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Cardinal Health

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Boehringer Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Men’s Liberty

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. TillaCare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Consure Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sterimed Group

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global External Urine Management Devices Market

Figure 4: Global External Urine Management Devices Market: Drivers

Figure 5: Global External Urine Management Devices Market: Challenges

Figure 6: Global External Urine Management Devices Market: Trends

Figure 7: Global External Urine Management Devices Market: Opportunity

Figure 8: Global External Urine Management Devices Market: Restraint

Figure 9: Global External Urine Management Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global External Urine Management Devices Market Value (USD Million) By Region

Figure 19: Global External Urine Management Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global External Urine Management Devices Market Value (USD Million) By Region

Figure 27: Global External Urine Management Devices Market Share (%) By: Regions (2032)

Figure 28: Global External Urine Management Devices Market Volume (K) By Region

Figure 29: Global External Urine Management Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global External Urine Management Devices Market Value (USD Million) By Region

Figure 37: Global External Urine Management Devices Market Share (%) By: Regions (2032)

Figure 38: Global External Urine Management Devices Market Volume (K) By Region

Figure 39: Global External Urine Management Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global External Urine Management Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global External Urine Management Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global External Urine Management Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global External Urine Management Devices Market Value (USD Million) By Region

Table 14: Global External Urine Management Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global External Urine Management Devices Market Volume (K) By Region

Table 31: Global External Urine Management Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global External Urine Management Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global External Urine Management Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global External Urine Management Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Company Basic Information And Sales Area

Table 52: BD Company. Products Portfolio

Table 53: Stryker (including Sage) Basic Information And Sales Area

Table 54: Stryker (including Sage). Products Portfolio

Table 55: Teleflex Basic Information And Sales Area

Table 56: Teleflex. Products Portfolio

Table 57: B. Braun Basic Information And Sales Area

Table 58: B. Braun. Products Portfolio

Table 59: Coloplast Basic Information And Sales Area

Table 60: Coloplast. Products Portfolio

Table 61: Hollister Basic Information And Sales Area

Table 62: Hollister. Products Portfolio

Table 63: Cardinal Health Basic Information And Sales Area

Table 64: Cardinal Health. Products Portfolio

Table 65: Boehringer Laboratories Basic Information And Sales Area

Table 66: Boehringer Laboratories. Products Portfolio

Table 67: Men’s Liberty Basic Information And Sales Area

Table 68: Men’s Liberty. Products Portfolio

Table 69: TillaCare Basic Information And Sales Area

Table 70: TillaCare. Products Portfolio

Table 71: Consure Medical Basic Information And Sales Area

Table 72: Consure Medical. Products Portfolio

Table 73: Sterimed Group Basic Information And Sales Area

Table 74: Sterimed Group. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global External Urine Management Devices Market Value (USD Million) By Region

Table 84: Global External Urine Management Devices Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global External Urine Management Devices Market Volume (K) By Region

Table 101: Global External Urine Management Devices Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

External Urine Management Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	586.00 million
Revenue forecast in 2033	1.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD Company; Stryker (including Sage); Teleflex; B. Braun; Coloplast; Hollister; Cardinal Health; Boehringer Laboratories; Men’s Liberty; TillaCare; Consure Medical; Sterimed Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

External Urine Management Devices Segmentation Breakdown9 items

Application

Hospitals

Clinics

Home Care

Others

Types

Condom Caths

Indwelling Caths

Others

Regional Insights

Loading chart…

Competitive Landscape

BD: R&D investment in antimicrobial catheter coatings

Stryker (Sage): Portfolio expansion via acquisition of niche OEMs

Teleflex: Vertical integration to secure raw material sourcing

B. Braun: Cost advantages through local manufacturing in Asia

Coloplast: Diversified product lines targeting chronic urology patients

Hollister: Strategic partnerships with hospital procurement networks

Key External Urine Management Devices Companies12 items

BD Company

Stryker (including Sage)

Teleflex

B. Braun

Coloplast

Hollister

Cardinal Health

Boehringer Laboratories

Men’s Liberty

TillaCare

Consure Medical

Sterimed Group

Market Ecosystem

Raw material/component suppliers — supply polymers, adhesives, and absorbent materials for device production

OEMs/Manufacturers — design and produce external urine management devices for medical and home use

Technology providers — develop sensor or monitoring technologies for smart urine management systems

Distributors/Channel partners — manage logistics and supply chains to healthcare providers and retail pharmacies

Service providers/After-sales — handle installation, training, and maintenance for institutional buyers

End users — include hospitals, long-term care facilities, and individuals with urological conditions

Regulators/standards bodies — set compliance and safety certifications for product market entry

Recent Industry Insights

Recent Developments in the _External Urine Management Devices_ industry trends4 items

B. Braun acquired a specialty medical device startup in 2024 to expand its portfolio of urological solutions.

Smith & Nephew launched a connected catheter system with real-time flow monitoring in early 2025.

The FDA introduced updated guidelines in 2024 to accelerate approval for devices incorporating antimicrobial polymers.

Startups like UroTech raised $20 million in 2024 for AI-powered urinary health analytics platforms.

Analyst Overview

Table of Contents